• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION PROMUS ELEMENT PLUS; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION PROMUS ELEMENT PLUS; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number 9394
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Ventricular Tachycardia (2132); Cardiogenic Shock (2262); Obstruction/Occlusion (2422)
Event Date 03/05/2020
Event Type  Injury  
Manufacturer Narrative
Device is a combination product.
 
Event Description
It was reported that during the procedure, patient deterioration occurred.Vascular access was obtained via the femoral artery.The 75% stenosed, long, eccentric, target lesion was located in the moderately tortuous right coronary (rca) artery.Predilatation was performed several times with a 2mm x 10mm semi compliant balloon.While the physician was positioning the 3.0 x 38mm promus element plus drug-eluting stent in the target lesion, the condition of the patient deteriorated and developed multiple problems.There was a disruption of flow to the distal rca associated with ischemic ventricular tachycardia and unstable hemodynamics.The patient was almost in a state of cardiogenic shock.To prioritize the patient stability, the physician removed the stent delivery system and other devices related to the procedure and abandoned the procedure.The patient was immediately taken to the intensive care unit where critical care was implemented.The patient was restless and in critical condition.The patient was treated with optimal medical therapy and when stabilized, was referred for coronary artery bypass graft.
 
Event Description
It was reported that during the procedure, patient deterioration occurred.Vascular access was obtained via the femoral artery.The 75% stenosed, long, eccentric, target lesion was located in the moderately tortuous right coronary (rca) artery.Predilitation was performed several times with a 2mm x 10mm semi compliant balloon.While the physician was positioning the 3.0 x 38mm promus element plus drug-eluting stent in the target lesion, the condition of the patient deteriorated and developed multiple problems.There was a disruption of flow to the distal rca associated with ischemic ventricular tachycardia and unstable hemodynamics.The patient was almost in a state of cardiogenic shock.To prioritize the patient stability, the physician removed the stent delivery system and other devices related to the procedure and abandoned the procedure.The patient was immediately taken to the intensive care unit where critical care was implemented.The patient was restless and in critical condition.The patient was treated with optimal medical therapy and when stabilized, was referred for coronary artery bypass graft.
 
Manufacturer Narrative
Device is a combination product.Device returned to manufacturer: a visual examination of the stent found no issues.There was no sign of damage, stretching or lifting of the stent struts.The stent showed no signs of movement and was set between the proximal and distal markerbands.The crimped stent outer diameter was measured within maximum crimped stent profile measurement per specifications.The balloon was reviewed, and no issues were noted.The balloon wings were tightly wrapped and evenly folded and were not subjected to positive pressure.A visual and tactile examination of the hypotube found a kink located at 32.8cm distal to distal end of strain relief.A visual and tactile examination of the shaft polymer extrusion found no issues.Visual and microscopic examination found no issues with the tip.No other issues were identified during the product analysis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS ELEMENT PLUS
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key9900589
MDR Text Key187714716
Report Number2134265-2020-04056
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup
Report Date 06/11/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/30/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/23/2021
Device Model Number9394
Device Catalogue Number9394
Device Lot Number0024518121
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/14/2020
Date Manufacturer Received05/26/2020
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age68 YR
-
-